8:00-8:30 |
Registration and Coffee |
8:30-9:15 |
State of the Neurotechnology Industry: 2024
James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the neurotechnology industry. He surveys changes in the competitive landscape that have occurred over the years, the most significant events of the last year, and challenges confronting the industry in years ahead. |
9:15-10:00 |
Keynote Address
Raymond Cohen, CEO, Axonics Inc. |
10:00-10:30 |
Refreshment Break |
10:30-11:15 |
Market Share Battles: Neuromodulation's Competitive Outlook
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Alexander Yeh, Ph.D., CTO, Neuspera Medical
Nandan Lad, M.D., Ph.D., Duke Neurosurgery
Victor Pikov, Ph.D., Contributing Editor, Neurotech Reports
Several segments of the neuromodulation industry have witnessed new competition as new entrants with new devices challenge the incuments. In this session, we'll look at new battlegrounds in treating pain, brain disorders, and other indications. |
11:15-12:00 |
Looking for the Exit: Investors Exploit Renewed Interest in Neurotech
James Cavuoto, Editor, Neurotech Reports, Moderator
Suraj Mudichintala, Senior Associate, Action Potential Venture Capital
Jordi Parramon, Ph.D., General Partner, Nexus NeuroTech Ventures
In this session, representatives from several investment firms targeting neuromodulation offer their insights on the most promising areas. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec Medical |
1:30-3:00 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Kial Gramley, Chief Product Officer, Backstop Neural
Ludovica Labruna, Ph.D, CEO, Magnetic Tides
Jeff Erb, CEO, Paxos Medical
Luca Ravagnan, CEO, WISE srl
Amy Baxter, M.D., CEO, Harmonic Pain Solutions
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
BCI Frenzy: Separating the Facts from the Hype in Brain Implant Market
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Vikash Gilja, Ph.D.,Chief Scientific Officer, Paradromics
Craig Mermel, President, Precision Neuroscience
Marcus Gerhardt, Co-founder and CEO, Blackrock Neurotech
While the news media has showered the space with wall-to-wall coverage, not all vendors and not all applications have equal promise. In this session, we'll look at the likely winners and also-rans in this market.
|
4:15-5:00 |
The Three-Legged Stool: Neurotech Vendors Tackle Reimbursement Issues
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Katherine Neuenfeldt, Senior Vice President, Commercial Strategies, Presidio Medical
Mark Domyahn, Partner, J.D. Lymon Group
Vendors of both implantable and noninvasive neuromodulation systems are fighting a constant battle to obtain coding, coverage, and sufficient pricing from CMS and private insurers, In this session, we'll explore recent activity in this space and examine the outlook for the future.
|
5:00-7:00 |
Cocktail Reception, Sponsored by MST
|
|
|
8:00:8:30 |
Registration and Coffee |
8:30-9:15 |
Keynote Address
Carolina Aguilar, CEO, INBRAIN Neuroelectronics
|
9:15-10:00 |
Peripheral Vision: Neurotech Startups Exploit New PNS Targets
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Lawrence Poree, M.D., Professor of Anesthesiology, UCSF School of Medicine
Jon Ruais, CCO, Nalu Medical
Manfred Franke, Ph.D., CEO, NeuronOff Inc.
Several new firms have emerged that target peripheral nerves, rather than the central nervous system, with neuromodulation therapies. In this session we'll look at a few of the most promising technologies and applications.
|
10:00-10:30 |
Coffee Break
|
10:30-11:15 |
Biomarking Your Territory: Neurosensing Technologies Enhance Closed-Loop Neuromodulation
Victor Pikov, Contributing Editor, Neurotech Reports, Moderator
Scott Stanslaski, Senior Distinguished Engineer, Medtronic
Martin Schuettler, CTO, CorTec GmbH
Brett Wingeier, Ph.D., Vice-President, Research and Development, NeuroPace Inc.
Closed-loop neuromodulation has become increasingly important in both brain and spinal cord stimulation. In this session, we'll look at different strategies for modifying stimulation parameters based on relevant neural signals. |
11:15-12:00 |
Consumer Be Aware: Neurotech Products Move Beyond Healthcare Applications
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Emily Mirro, President and Co-Founder, SynchNeuro Inc.
Nathan Intrator, Founder, Neurosteer
Liron Nunez Weissman, CEO, Corundum Neuroscience
While the neurotech industry to date has been largely driven by devices that treat or diagnose medical conditions, a new realm of consumer-facing products has emerged with a range of novel applications. In this session, we'll look at some of the most promising product categories.. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec Medical
Presentation of 2024 Gold Electrode Awards |
1:30-3:00 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Imanuel Lerman, M.D., CEO, InflammaSense, Inc.
Katya Sverdlov, CEO and Co-Founder, JelikaLite
Pawel Soluch, CEO and Co-Founder, Spinally Medical
Andy Gotshalk, CEO, Neurologic Solutions
Roy Burstin, CEO, Eno
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Manufacturing Our Future: New Materials and Methods Pave the Way for Neurotech Growth
James Cavuoto, Editor, Neurotech Reports, Moderator
Asheesh Divetia, Ph.D., General Manager, Cirtec Medical
Eran Benjamin, Business Development Manager, Micro Systems Technologies
Uli Gommel, CTO, Neo-Bionica
Future generations of neurotech products will benefit from advances in manufacturing and engineering technology. In this session, we'll explore some of the most promising innovations in materials science and manufacturing technology. |
4:15-5:00 |
Facing the Public: An Editorial Perspective
James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Jeremy Koff, Senior Consulting Editor, Neurotech Reports
Jo Jo Platt, Senior Contributing Editor, Neurotech Reports
Sharena Rice, Ph.D., Contributing Editor, Neurotech Reports
Victor Pikov, Ph.D., Contributing Editor, Neurotech Reports
In this wrap-up session, Neurotech Reports team of editors will offer their views on recent controversies facing the neuromodulation industry, including ethical concerns, dealing with bad press, and legislative and regulatory developments.
|
5:00-7:00 |
Cocktail Reception, Sponsored by MST |
|
|